| Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB CY Wang, JC Cusack, R Liu, AS Baldwin Nature medicine 5 (4), 412-417, 1999 | 1334 | 1999 |
| Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression LB Owen-Schaub, W Zhang, JC Cusack, LS Angelo, SM Santee, ... Molecular and cellular biology, 1995 | 1095 | 1995 |
| Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-κB inhibition JC Cusack Jr, R Liu, M Houston, K Abendroth, PJ Elliott, J Adams, ... Cancer research 61 (9), 3535-3540, 2001 | 758 | 2001 |
| Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence GM Fuhrman, SD Leach, CA Staley, JC Cusack, C Charnsangavej, ... Annals of surgery 223 (2), 154-162, 1996 | 525 | 1996 |
| Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-κB SM Russo, JE Tepper, AS Baldwin Jr, R Liu, J Adams, P Elliott, ... International Journal of Radiation Oncology* Biology* Physics 50 (1), 183-193, 2001 | 468 | 2001 |
| Minimal residual disease detection using a plasma-only circulating tumor DNA assay in patients with colorectal cancer AR Parikh, EE Van Seventer, G Siravegna, AV Hartwig, A Jaimovich, Y He, ... Clinical Cancer Research 27 (20), 5586-5594, 2021 | 239 | 2021 |
| Inducible chemoresistance to 7-ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxycamptothecin (CPT-11) in colorectal cancer cells and a xenograft model is overcome by … JC Cusack Jr, R Liu, AS Baldwin Jr Cancer research 60 (9), 2323-2330, 2000 | 213 | 2000 |
| Survival factors in 186 patients younger than 40 years old with colorectal adenocarcinoma. JC Cusack, GG Giacco, K Cleary, BS Davidson, F Izzo, J Skibber, J Yen, ... Journal of the American College of Surgeons 183 (2), 105-112, 1996 | 177 | 1996 |
| Rationale for the treatment of solid tumors with the proteasome inhibitor bortezomib JC Cusack Cancer Treatment Reviews 29, 21-31, 2003 | 162 | 2003 |
| Merkel cell carcinoma: 30-year experience from a single institution JA Santamaria-Barria, GM Boland, BY Yeap, V Nardi, D Dias-Santagata, ... Annals of surgical oncology 20, 1365-1373, 2013 | 155 | 2013 |
| Expression of human α (1, 3) fucosyltransferase antisense sequences inhibits selectin-mediated adhesion and liver metastasis of colon carcinoma cells BW Weston, KM Hiller, JP Mayben, GA Manousos, KM Bendt, R Liu, ... Cancer research 59 (9), 2127-2135, 1999 | 146 | 1999 |
| Fas and Fas ligand interactions in malignant disease. L Owen-Schaub, H Chan, JC Cusack, J Roth, LL Hill International journal of oncology 17 (1), 5-17, 2000 | 128 | 2000 |
| Hereditary breast and ovarian cancer and other hereditary syndromes: using technology to identify carriers B Drohan, CA Roche, JC Cusack, KS Hughes Annals of surgical oncology 19, 1732-1737, 2012 | 124 | 2012 |
| Targeting the NF-κB pathway in cancer therapy DJ Erstad, JC Cusack Surgical Oncology Clinics 22 (4), 705-746, 2013 | 123 | 2013 |
| Activation of PI3K signaling in Merkel cell carcinoma V Nardi, Y Song, JA Santamaria-Barria, AK Cosper, Q Lam, AC Faber, ... Clinical Cancer Research 18 (5), 1227-1236, 2012 | 123 | 2012 |
| In vivo adenovirus-mediated p53 tumor suppressor gene therapy for colorectal cancer. FR Spitz, D Nguyen, JM Skibber, J Cusack, JA Roth, RJ Cristiano Anticancer research 16 (6B), 3415-3422, 1996 | 123 | 1996 |
| Potentiation of chemotherapeutic agents following antagonism of nuclear factor kappa B in human gliomas KD Weaver, S Yeyeodu, JC Cusack, AS Baldwin, MG Ewend Journal of neuro-oncology 61, 187-196, 2003 | 122 | 2003 |
| NF-κ B and chemoresistance: Potentiation of cancer drugs via inhibition of NF-κ B JC Cusack, R Liu, AS Baldwin Drug Resistance Updates 2 (4), 271-273, 1999 | 111 | 1999 |
| The Chicago consensus on peritoneal surface malignancies: management of appendiceal neoplasms Annals of surgical oncology 27 (6), 1753-1760, 2020 | 110* | 2020 |
| Managing unsuspected tumor invasion of the superior mesenteric-portal venous confluence during pancreaticoduodenectomy JC Cusack Jr, GM Fuhrman, JE Lee, DB Evans The American journal of surgery 168 (4), 352-354, 1994 | 109 | 1994 |
